Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1216076.RAgfmHQrWpz1pfOObLDQAOQGBpuWkuYIsaoN2cFVEICkM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1216076.RAgfmHQrWpz1pfOObLDQAOQGBpuWkuYIsaoN2cFVEICkM130_assertion type Assertion NP1216076.RAgfmHQrWpz1pfOObLDQAOQGBpuWkuYIsaoN2cFVEICkM130_head.
- NP1216076.RAgfmHQrWpz1pfOObLDQAOQGBpuWkuYIsaoN2cFVEICkM130_assertion description "[Importantly, MARCKS knockdown in combination with bortezomib treatment overcame bortezomib resistance, significantly inhibited tumor growth and prolonged host survival in a MM xenograft model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1216076.RAgfmHQrWpz1pfOObLDQAOQGBpuWkuYIsaoN2cFVEICkM130_provenance.
- NP1216076.RAgfmHQrWpz1pfOObLDQAOQGBpuWkuYIsaoN2cFVEICkM130_assertion evidence source_evidence_literature NP1216076.RAgfmHQrWpz1pfOObLDQAOQGBpuWkuYIsaoN2cFVEICkM130_provenance.
- NP1216076.RAgfmHQrWpz1pfOObLDQAOQGBpuWkuYIsaoN2cFVEICkM130_assertion SIO_000772 25179733 NP1216076.RAgfmHQrWpz1pfOObLDQAOQGBpuWkuYIsaoN2cFVEICkM130_provenance.
- NP1216076.RAgfmHQrWpz1pfOObLDQAOQGBpuWkuYIsaoN2cFVEICkM130_assertion wasDerivedFrom befree-2016 NP1216076.RAgfmHQrWpz1pfOObLDQAOQGBpuWkuYIsaoN2cFVEICkM130_provenance.
- NP1216076.RAgfmHQrWpz1pfOObLDQAOQGBpuWkuYIsaoN2cFVEICkM130_assertion wasGeneratedBy ECO_0000203 NP1216076.RAgfmHQrWpz1pfOObLDQAOQGBpuWkuYIsaoN2cFVEICkM130_provenance.